Andere talen NeuroPace, Inc.

Aandelen

NPCE

US6412881053

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,39 ^USD	+3,08%		-4,22%	+29,87%

14/03	NEUROPACE, INC. : Wells Fargo Securities verhoogt advies	ZM
12/03	NEUROPACE, INC. : JPMorgan Chase herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024	17/04
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference	27/03
North American Morning Briefing : Inflation -2-	15/03
NeuroPace Shares Decline Following Q4 Financial Results	06/03
NeuroPace, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
NeuroPace, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Earnings Flash (NPCE) NEUROPACE Reports Q4 Revenue $18M, vs. Street Est of $17.7M	05/03
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million	05/03
NeuroPace, Inc. Provides Earnings Guidance for the Year 2024	05/03
NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	15/02
NeuroPace, Inc Announces Resignation of Irina Ridley as Chief Legal Officer and Corporate Secretary	07/02
NeuroPace Preliminary Q4 Revenue Beats Street View; Shares Rise	08/01
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates	08/01
NeuroPace, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter Ended December 31, 2023	08/01
NeuroPace, Inc. Revises Revenue Guidance for the Full Year 2023	08/01
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	21/12
NeuroPace, Inc. Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study	21/12
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference	19/12
NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	05/12
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration	04/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NeuroPace, Inc.

Aandelen

NPCE

US6412881053

Andere talen

Filters